These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 22826514)

  • 1. Childhood medulloblastoma: the paradigm shift in molecular stratification and treatment profile.
    Sadighi Z; Vats T; Khatua S
    J Child Neurol; 2012 Oct; 27(10):1302-7. PubMed ID: 22826514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medulloblastoma: what is the role of molecular genetics?
    Entz-Werle N; Carli ED; Ducassou S; Legrain M; Grill J; Dufour C
    Expert Rev Anticancer Ther; 2008 Jul; 8(7):1169-81. PubMed ID: 18588461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid diagnosis of medulloblastoma molecular subgroups.
    Schwalbe EC; Lindsey JC; Straughton D; Hogg TL; Cole M; Megahed H; Ryan SL; Lusher ME; Taylor MD; Gilbertson RJ; Ellison DW; Bailey S; Clifford SC
    Clin Cancer Res; 2011 Apr; 17(7):1883-94. PubMed ID: 21325292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medulloblastoma in China: clinicopathologic analyses of SHH, WNT, and non-SHH/WNT molecular subgroups reveal different therapeutic responses to adjuvant chemotherapy.
    Zhang ZY; Xu J; Ren Y; Li KK; Ng HK; Mao Y; Zhong P; Yao Y; Zhou LF
    PLoS One; 2014; 9(6):e99490. PubMed ID: 24932704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological variants of medulloblastoma are the most powerful clinical prognostic indicators.
    Massimino M; Antonelli M; Gandola L; Miceli R; Pollo B; Biassoni V; Schiavello E; Buttarelli FR; Spreafico F; Collini P; Giangaspero F
    Pediatr Blood Cancer; 2013 Feb; 60(2):210-6. PubMed ID: 22693015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histologic features and prognosis in pediatric medulloblastoma.
    Verma S; Tavaré CJ; Gilles FH
    Pediatr Dev Pathol; 2008; 11(5):337-43. PubMed ID: 18201118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medulloblastoma molecular dissection: the way toward targeted therapy.
    Remke M; Ramaswamy V; Taylor MD
    Curr Opin Oncol; 2013 Nov; 25(6):674-81. PubMed ID: 24076581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Subgrouping of Medulloblastoma: Impact Upon Research and Clinical Practice.
    Gupta T; Shirsat N; Jalali R
    Curr Pediatr Rev; 2015; 11(2):106-19. PubMed ID: 26133181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical Surrogates for Molecular Stratification in Medulloblastoma.
    Chinnam D; Saraswati A; Jogunoori S; Verma A; Kiran T; Salunke P; Gupta N; Kumar N; Madan R; Radotra BD; Gupta K
    Appl Immunohistochem Mol Morphol; 2023 Sep; 31(8):561-568. PubMed ID: 37471625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential impact of tumour biology on improved clinical practice for medulloblastoma: progress towards biologically driven clinical trials.
    Pizer BL; Clifford SC
    Br J Neurosurg; 2009 Aug; 23(4):364-75. PubMed ID: 19637007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classic and desmoplastic medulloblastoma: complete case reports and characterizations of two new cell lines.
    Holthouse DJ; Dallas PB; Ford J; Fabian V; Murch AR; Watson M; Wong G; Bertram C; Egli S; Baker DL; Kees UR
    Neuropathology; 2009 Aug; 29(4):398-409. PubMed ID: 19077040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medulloblastoma: recurrence and metastasis.
    Aref D; Croul S
    CNS Oncol; 2013 Jul; 2(4):377-85. PubMed ID: 25054581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on the integrated histopathological and genetic classification of medulloblastoma - a practical diagnostic guideline.
    Pietsch T; Haberler C
    Clin Neuropathol; 2016; 35(6):344-352. PubMed ID: 27781424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological and molecular heterogeneity of medulloblastoma.
    Gulino A; Arcella A; Giangaspero F
    Curr Opin Oncol; 2008 Nov; 20(6):668-75. PubMed ID: 18841049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medulloblastomas in adults: prognostic factors and lessons from paediatrics.
    Fellay CN; Frappaz D; Sunyach MP; Franceschi E; Brandes AA; Stupp R
    Curr Opin Neurol; 2011 Dec; 24(6):626-32. PubMed ID: 22027544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medulloblastoma, WNT-activated/SHH-activated: clinical impact of molecular analysis and histogenetic evaluation.
    Cambruzzi E
    Childs Nerv Syst; 2018 May; 34(5):809-815. PubMed ID: 29582169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood medulloblastoma.
    Massimino M; Giangaspero F; Garrè ML; Gandola L; Poggi G; Biassoni V; Gatta G; Rutkowski S
    Crit Rev Oncol Hematol; 2011 Jul; 79(1):65-83. PubMed ID: 21129995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medulloblastoma in the age of molecular subgroups: a review.
    Juraschka K; Taylor MD
    J Neurosurg Pediatr; 2019 Oct; 24(4):353-363. PubMed ID: 31574483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of the prognostic factors in medulloblastoma of children and adults.
    Brandes AA; Paris MK
    Crit Rev Oncol Hematol; 2004 May; 50(2):121-8. PubMed ID: 15157661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New perspectives in the treatment of adult medulloblastoma in the era of molecular oncology.
    Brandes AA; Bartolotti M; Marucci G; Ghimenton C; Agati R; Fioravanti A; Mascarin M; Volpin L; Ammannati F; Masotto B; Gardiman MP; De Biase D; Tallini G; Crisi G; Bartolini S; Franceschi E
    Crit Rev Oncol Hematol; 2015 Jun; 94(3):348-59. PubMed ID: 25600839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.